Enteral Feeding Devices Market : A Comprehensive Overview of the Current Trends

Market Overview

The global Enteral Feeding Devices Market size is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Segmentation:

The global enteral feeding devices market has been segmented on the basis of product, age group, indication, end user, and region. 

·       By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·       On the basis of age group, the market has been divided into adults and pediatrics. 

·       By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·       Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Epilepsy Market Insights Overview, Industry Analysis and Forecasts Report 2032

Overview:

Epilepsy can be classed as a major neurological disorder where the brain activity becomes abnormal and triggers unusual behavior and sensations. The disorder is discernible in young children and young adults and requires proper attention in time before it can impact the body in an adverse way.

The Epilepsy Market Size is expected to reach USD 1.10 Billion by 2032 at 7.2% CAGR during the forecast period 2023-2032. The regional market is showing ample scope where a high prevalence of the disease can inspire growth in diverse regions.

In addition, the global market would benefit from the presence of countries in the African region where various global bodies are trying to launch initiatives to assist local doctors in curbing the diseases. However, poor economies can detract the growth rate.

Competitive Landscape:

MRFR’s analysis of various companies to get close to factors that can decipher the market growth and assist in the implementation of several market strategies. The recording of these moves can inspire a better understanding of the global scenario. Epilepsy Market Players are.

GlaxoSmithKline PLC (U.K.),

LivaNova PLC (U.K.),

Medtronic PLC (Ireland),

Eisai Co. Ltd. (Japan),

Pfizer Inc. (U.S.),

NeuroPace Inc. (U.S.),

UCB SA (Belgium),

Johnson & Johnson Services Inc. (U.S.),

Novartis AG (Switzerland),

GW Pharmaceuticals PLC (U.K.),

Abbott Laboratories (U.S.). 

These companies are set on a path to solidify their own market stance and improve scopes for expansion in the coming days.

Segmentation:

The report on the epilepsy market encompasses segments like by condition, diagnosis & treatment, and end-use to facilitate an easy understanding of the market and gauge well how the regional market would shape up in the coming years.

• By condition, the market report on epilepsy covers epilepsy drug-resistant/intractable epilepsy and others. The former had a market share of 29.5% in 2017. The global market for the segment can provide ample growth opportunities as the requirement for drug-resistant therapies can trigger better growth. The ‘others’ segment has a market growth possibility of 7.83% CAGR during the forecast period.
• By diagnosis and treatment, the market report on epilepsy includes diagnosis and treatment. The diagnosis segment can be sub-segmented into blood tests, imaging devices, and others. The treatment segment includes neurostimulation devices, anti-epileptic drugs, ketogenic diet, brain surgery, and others. The treatment segment had 66.2% of the global share in 2017. Cost-efficiency can be taken into consideration to understand market growth possibilities.
• By end-users, the epilepsy market can include clinics, hospitals, diagnostic centers, ambulatory surgical centers, and others. The hospital segment had a market share of 29.3% in 2017.

Regional Analysis:

The global market, upon considering from a region-specific angle, can be segmented into North America, Europe, and the Asia Pacific as major contributors. It also covers Latin America and the Middle East & Africa (MEA) as countries displaying moderate growth but with the potential to improve scenario. The Americas has better market coverage and it had almost 41% of the global market share in 2017. Europe is on a track to display 8.31% CAGR during the forecast period. The regional market has potential to explore opportunities regarding research and development, and it is getting backed by the constant influx of investments. Countries like the UK, France, Germany, and others are contributing much to take the regional market ahead in the coming years.

The Asia Pacific (APAC) market is showing opportunities to score well past a valuation mark of USD 2,046.57 million by 2023. Most of the traction to grow forward would come from India, South Korea, and China where a large population is triggering high ingress of treatments needed for that.

Related reports:

https://xiglute.com/blogs/20378415/188561/laboratory-information-systems-market-research-report-forecas

https://www.hongkongwomenorg.com/read-blog/199

https://social.ibspoint.com/blogs/1618/Wound-Closure-Devices-Market-Share-Keyplayers-and-trends-till-2032

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Surgical Snare Market Insights, Growth Analysis, CAGR Status & forecast to 2032

Overview:

Market Research Future (MRFR) made revealed several possibilities that could boost global Surgical Snare Market Size, growth and ensure a better profit in the coming years. The Surgical Snare Market is anticipated to reach USD 1.19 Billion by 2032 at 9.1% CAGR during the forecast period 2023-2032.

Among the major factors that would ensure profitability for the market, the demand for minimally invasive surgeries is expected to score big. On the other hand, hike in endoscopy could boost growth for the global surgical snare market. Technological progress would also help the market is expanding its operational scope. The latest developments increase the intake of the product. 

Competitive Landscape:

These companies are investing heavily in building partnerships to increase their profit through sharing of portfolios, cross-branding, and others. Mergers and acquisitions are expected to create better growth options for these companies. Branding strategy, increase in expenditure to boost the research and development sector to inspire product launches, and other expansion strategies are expected to boost the global market prospect. MRFR made an attempt to register different changes and understand the market flow by gauging the outcomes of the latest proceedings. 

Key Players-

The surgical snare market players depends mostly on the tactical innovations launched by companies like

Olympus,

CONMED,

Boston Scientific,

Medtronic,

Steris,

Sklar Surgical Instruments, and

others.

Segmentation:

The global market report on the surgical snare market, as discussed by MRFR, has been segmented into usability, application, and end user. Insights revealed by the analysts are expected to boost the market prospect and facilitate growth in the coming years y helping in devising better strategies.

• By usability, the global review on the surgical snare market has been segmented into reusable and single-use. The easy disposable ones are getting substantial traction for their convenience of use. In the case of reusable ones, demand to reduce waste may trigger growth. 
• By application, the global report on the surgical snare market has been segmented on the basis of endoscopy, laparoscopy, neuroendoscopy, otoscopy, laryngoscopy, cystoscopy, and others. The endoscopy segment is expected to provide better traction to the market.
• By the end-user, the global study on the surgical snare market has been segmented on the basis of ambulatory surgical centers, hospitals & clinics, and others. Better infrastructure would allow the hospitals & clinics segment is expected to score more. Easy inclusion of various procedures would help the market gain a better prospect. 

Regional Analysis:

The Americas is expected to benefit the most from this growth of the surgical snare market. North America, with better growth opportunities due to superior infrastructure, increased investment in the research and development sector to boost the market outcome, and others are inspiring the surge constantly. In South America, the growth would be a bit challenging as several countries from the region are of poor origins. In Europe, the market would benefit more from government initiatives to improve service and impact the sector with better products. France, Germany, the UK, Italy, and others would create a growth opportunity. In Asia Pacific, the revamping process of the healthcare industry in several countries may boost the market as a whole. 

Industry News:

• Recently, Olympus, a company known for its technological prowess in designing and delivering innovative solutions to serve medical and surgical procedures in a better way, announced the launching of their new SnareMaster Plus hybrid hot/cold snare in the US. This allows Olympus to cover the diverse range of procedural applications for polypectomy using its SnareMaster portfolio. The portfolio includes products like the SnareMaster Soft and the SnareMaster Spiral.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Pain Management Devices Market Insights Research Report 2023-2032

Pain Management Devices Market – Overview

The Pain Management Devices Market Size can anticipate expansion at a rate of 7.1% from 2023 to 2032, believes MRFR (Market Research Future). MRFR further expects the market share to touch USD 83.51 billion by 2032.

Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector.

The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is anticipated to demonstrate a good growth rate through the forecast period.

Key Players:

Pain Management, Inc (US),

Baxter International Inc. (US),

Medtronic Plc (US),

St. Jude Medical (US),

Boston Scientific Corporation (US),

Codman and Shurtleff, Inc. (US),

Stryker Corporation (US),

Bio-Medical Research (BMR) Ltd. (UK),

Hospira Inc. (US),

Kimberly-Clark Corporation (US),

Smiths Medical (UK),

DJO Global LLC (US) and

1. Braun Melsungen AG. (Germany)

are a few of the key Pain Management Devices Market Players.

Industry Segments

The industry for Pain Management Devices Market is segmented into the segments of type and application.

• On basis of type, the market segment comprises of stimulators, ablation devices and pumps. The ablation devices are moreover divided into microwave devices and cryoablation devices among others. The stimulators are sub segmented into neuromodulator devices and transcutaneous electrical nerve stimulation devices. The neuromodulator devices are additionally sub segmented into intrathecal pain pump, spinal cord stimulator, dorsal root ganglion stimulation and peripheral nerve stimulator among others. The pumps are additionally sub divided into analgesic infusion pumps and others. The analgesic infusion pumps are also segmented into patient control infusion pumps, external infusion pumps, intrathecal infusion pumps among others. Lastly,
• based on application, the segments comprise of migraine, musculoskeletal pain, cancer pain, and others.

Global Competitive Analysis

Competitors who are a part of the industry have devised their corporate strategy blueprint in a way that that can bring the best outcomes for development in the current scenario, while also simultaneously delivering customer value unfailingly. The ability to sustain their competitive edge is one of the main causes fuelling their efforts in this period. The scope for development in the industry appears to be promising through the forecast period. The rising interest for diversification in the industry, has indirectly allowed the players to utilize many prospects available in the industry. This scenario has created opportunities for portfolio improvements along with diversification in the sector, which has improved the scenario for market competitors tremendously in this industry. The organizations in this industry are also trying to enhance and maintain financial liquidity that can be crucial to invest in growth opportunities as and when they become available.

Detailed Regional Analysis

The regional analysis for the Pain Management Devices Market Report covers regions such as Europe, North America, Asia Pacific, and rest of the world. The North American region is the chief region for devices that control pain management followed by the European region. The expansion of the industry is supported by huge investments and development in research along with new product development. The degree of development and research in neurostimulation based pain management devices has secured the expansion of the sector. The Asia pacific region is a quickly growing region for the pain management devices. Owing to a huge population base, the expansion in infrastructure and rising occurrence of many diseases in the region has created a better impetus for the expansion of the industry.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Prefilled Syringes Market In-depth Research by Forecast To 2032

Prefilled Syringes Market Overview 

Market Research Future (MRFR) studied the global prefilled syringes market Size valued at USD 79.5 billion in 2022 and is projected to grow from USD 83.6 Billion in 2023 to USD 1124.59 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% during the forecast period (2023 - 2032). 

The minimal drug wastage achieved through the increased in the utility of prefilled syringes has opened an attractive option for the growing pharmaceutical sector to invest. This is expected to promote the prefilled syringe market in the study period. The benefit of self-administration of medication offered by these syringes has increased its consumer based, thereby contributing to the overall growth of the prefilled syringe market.

The biologics and biosimilars sectors are observed as another major promoters of the prefilled syringe market. Other causes that are expected to propel the prefilled syringe Prefilled Syringes Market Insights are persistence of chronic diseases over a long time that necessitate the regular administration of drugs. Increase in chronic diseases, such as diabetes, is identified to enhance the development of prefilled syringes for parenteral drug delivery is the preferred route of administration for insulin. Ease of use and dosing errors elimination benefits offered prefilled syringe, along with the causes can favor the market. Greater dose precision, simplicity in design, and suitability for home use are other advantages of prefilled syringe that is expected to promote the market during the analysis period.

The utility of prefilled syringes for different therapeutics applications, other than conventional uses, such as vaccine dispensing, has also triggered the demand for the market. The rapid development of the medical industry over the past few years is also likely to contribute significantly to the rise of the market. In addition, the increase in demand for convenient drug delivery methods has paved way for the development of the market. This is due to the pharmaceutical industry pursues modern and more effective methods for introduction solutions for convenient administration of unit dose medication.

Prefilled syringes are disposable syringes that are already loaded with liquid medicine. They are used for many therapeutic biologic formulations, especially for expensive drugs or low volumes. They have benefits such as saving time, reducing nursing costs, ensuring accuracy, and preventing contamination.

Prefilled syringes have four key components: a plunger, stopper, barrel, and a needle. The plunger and stopper must fit tightly inside of the barrel but should glide through it when pressure is applied. The syringes can be made of glass or an advanced polymer.

Competitive Analysis

Medtronic, Terumo Corporation, OMPI (A Stevanato Group Company¸ Vetter Pharma International GmbH, Abbott¸ Gerresheimer AG, Nipro Corporation, Baxter, Schott AG, West Pharmaceutical, Becton, Dickinson and Company, and Weigao Group, among others are some top-notch companies that are operating in the prefilled syringes market Players as listed by MRFR.

Market Segmentation

The segment assessment of the prefilled syringes market Outlook is based out type, end users, material, and design.

The type-based segments of the prefilled syringes market Trends are conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to hold the largest share of market by 2024. 

The material-based segments of the prefilled syringe market are glass prefilled syringes and plastic prefilled syringes. The plastic syringes segment is expected to garner substantial revenue for the market. The expansion of the plastic syringe segment can be attributed to their increasing utility the pharmaceutical packaging. The glass prefilled syringes segment studies oil siliconized syringes and baked on silicone.

The design-based segments of the market are customized prefilled syringes, dual-chamber prefilled syringes, and single-chamber prefilled syringes. The Dual-chamber prefilled syringes segment can expand at 10.31% CAGR in the forecast tenure. The single-chamber prefilled syringes segment is likely to secure about 56% share for the overall prefilled syringe market by 2024.

The end-user-based segments of market are hospitals & clinics, and ambulatory surgical units among others. The hospitals segment is likely to grow with the rapid CAGR in the study period as the number of private and public hospitals are increasing.

Regional Analysis

In Europe, the prefilled syringe market can hold a decent share of the global market. Expansion of geriatric population, growing demand for better quality healthcare services and solutions, ongoing trend of home-based treatment, and hike in healthcare expenditure are causes that are likely to boost EU market. Similar causes are also observed as growth inducers in the Americas region. The Americas is likely to hold the second-largest market portion, following the Asia Pacific region. APAC prefilled syringe market can rise at 10.78% expansion rate in the forecast period. Moreover, factors such as, rapid adoption of plastic devices and modern healthcare developments are, expected to benefit the market in the review period. In the Middle East Asia, the surge in number of public hospitals and private clinics can promote the regional prefilled syringe market. market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Dental Bone Graft Substitutes Market Growth Outlook Trends, and Forecast by 2032

Market Synopsis:

Market Research Future (MRFR)’s latest study reveals that the global Dental Bone Graft Substitutes Market Size is expected to reach at 9.1% CAGR over the estimated 2023-2032. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years.

The painful procedure related to autografts have paved the way for developments in the Dental Bone Graft Substitutes Market. Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption.

Competitive Dashboard:

Sone of the key Dental Bone Graft Substitutes Market players profiled in the report includes

·        ACE Surgical Supply Company, Inc.,

·        Dentium Co., Ltd.,

·        BioHorizons IPH, Inc.,

·        Dentsply Sirona,

·        Medtronic plc,

·        Stryker Corporation,

·        Zimmer Biomet, and

·        Institut Straumann AG.

Market Segmentation:

·       By type, the global bone graft substitutes market is segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.

·        By application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.

The growth of the bone graft substitutes market is guided by the factors such as increasing orthopedic problems, exponential geriatric population, and rising demand for reconstructive orthopedic treatments. The adoption of bone graft substitutes in the oral healthcare sector is another factor responsible for catalysing the growth of the bone graft substitutes market through the assessment period.

The dental bone graft membrane market is poised to remain highly lucrative in the foreseeable future. However, risks associated with disease transmission in allografts and xenograft as well as graft rejection, improper fixation, etc. are prognosticated to restrict the market expansion over the forecast period.

Regional Insights:

By region, the global bone graft substitutes market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the largest share of the global market in 2016. It is expected to retain a significant share of the market by the end of 2027 striking a CAGR of 6.1%. The growth is attributable to the technological advancements in health care, the presence of key players, etc. The developed healthcare sector of the U.S. is poised to be one of the primary revenue generators in the regional bone graft substitutes market.

Europe is the second largest market for bone graft substitutes. It is estimated to thrive at 6.76% CAGR owing to increasing awareness about bone graft substitutes and rising healthcare expenditure. Meanwhile, Asia Pacific is set to register a relatively higher CAGR of 6.85% during the forecast period. The presence of fast-developing economies such as China and India are immensely supporting the growth of the bone graft substitutes market in the region. The trend is likely to perpetuate over the next couple of years.

The Middle East & Africa is expected to exhibit steady growth due to the developments in the healthcare sector in Gulf nations. However, the poor socio-economic situation in African regions remains an impediment to the market growth.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Precision Medicine Market Latest Research Report, Industry Growth & Business Revenue till 2032

Overview:

The global precision medicine market size is witnessing unprecedented growth due to people turning their focus more on personal healthcare. It could attain an astonishing CAGR of 12.5% during the forecast period (2023-2032). Precision medicine evolved from the concept that same medicine cannot function equally for two different individuals with the same disease as they have different gene structure. At the same time, medication depends on how well patients can respond to its dosage. Hence, the need for precision medicine. Market Research Future (MRFR), in their report, has included various drivers and segments that can produce a reliable prediction for the future market. Prevalent diseases such as cancer, diabetes, and others are boosting the precision medicine market as treatment of such diseases gets a better result with personalized medicine structure. Furthermore, its impact can significantly lower the cost of treatment.

However, a personal data breach can be seen as a major precision medicine market growth prohibition. The diagnostic cost can incur a high cost, stringent government policies, the risk with hardware and software failure, and lack of medical framework can hold back the market during the forecast period.

Market Insights:

Mergers, acquisitions, collaborations and other strategies dominate the market substantially when it comes to strategic decisions. For instance, Roche purchased Foundation Machine to better their portfolio. On the other hand, New Medicine Partners is trying to increase their market reach by proposing a plan based on personalized medicines to Kazakhstan officials to develop a plant there. 

Prominent players in the global precision medicine market include Abbott Laboratories (USA), Ab-Biotics SA (USA), Almac Group Ltd. (UK), Asuragen Inc (USA), Biobase GmbH (Germany), Biomérieux SA (France), Caris Life Sciences (USA), Cepheid Inc. (USA), Cetics Healthcare Technologies Gmbh (Germany), GE Healthcare (USA), GlaxoSmithKline PLC (UK), Healthcore Inc. (USA), IBM (USA), Innventis (Israel), Intel Corporation (USA), Johnson & Johnson (USA), Laboratory Corporation Of America Holdings (USA), Medtronic (USA), Molecular Health GmbH (Germany), Novartis (Switzerland), Pfizer Inc. (USA), Qiagen (Germany), Quest Diagnostics Inc (USA), Randox Laboratories Ltd. (UK), Sanofi Pharma (France), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceutical Industries Ltd. (Israel), and others.

Industry Trends:

Precision medicine is showing great promise for the cure of the Alzheimer’s disease. Two new drugs are waiting on the sideline for final approval; one called BAN2401 and the other Anavex 2-73. BAN2401’s use on patients shows a reduction in generation of proteins called amyloid plaques that cause memory loss.    

Recently, an article published in SLAS Technology (Society for Laboratory Automation and Screening) revealed that artificial intelligence (AI) is all set to impact precision medicine industry significantly as it can efficiently analyze small datasets and assist in the optimal design of drug combinations.

Segmentation:

The global precision medicine market can be segmented by ecosystem, sub-market, and therapeutics.

Based on the ecosystem, the precision medicine market can be segmented into clinical laboratories, diagnostic tool companies, healthcare IT/ big data companies, and pharma & biotech companies. Diagnostic tools segment has the largest market volume.

Sub-market segment of the precision medicine can be segmented by biomarker-based test, companion diagnostics, molecular diagnostics, pharmacogenomics, targeted therapeutics, and others. Company diagnostics is leading the segment.

Therapeutics-based segmentation of the precision medicine market includes cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, and others.

Regional Analysis:

Region-specific analysis of the precision medicine market encompasses North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America is the largest market for global precision medicine. The region has superior infrastructure, both in healthcare and biotechnology. It sets up the zone perfectly for research and developments assisting further in new product development.

Europe is the second-largest market for global precision medicine. Various investors are taking an interest in the sector and is helping in the development of new drugs. However, the developing regions market particularly, the APAC will be the fastest growing and is likely to be the key to the future. But the MEA region may not find much thrust due to but can expect steady growth.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America